Page last updated: 2024-12-06

benzo(a)pyrene 4,5-epoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzo(a)pyrene 4,5-epoxide: RN given refers to cpd with unspecifiedisomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37786
CHEBI ID34560
MeSH IDM0049402

Synonyms (31)

Synonym
benzo(a)pyrene 4,5-oxide
benzo(a)pyrene 4,5-epoxide
benzo(a)pyrene-4,5-epoxide
bp 4,5-epoxide
4,5-dihydrobenzo(a)pyrene-4,5-epoxide
benzo(1,2)pyreno(4,5-b)oxirene, 3b,4a-dihydro-
ccris 798
benz(a)pyrene 4,5-oxide
benzo(a)pyrene-4,5-oxide
bp 4,5-oxide
37574-47-3
benzo[a]pyrene-4,5-oxide
benzo[a]pyrene-4,5-epoxide
benzo(1,2)pyreno(4,5-b)oxirene, 3b,4a-dihydro-, (3br-cis)-
72010-12-9
72010-13-0
(+)-3b,4a-dihydrobenzo(1,2)pyreno(4,5-b)oxirene
benzo(1,2)pyreno(4,5-b)oxirene, 3b,4a-dihydro-, (+)-
(+-)-3b,4a-dihydrobenzo(1,2)pyreno(4,5-b)oxirene
64437-52-1
benzo(1,2)pyreno(4,5-b)oxirene, 3b,4a-dihydro-, (+-)-
4,5-dihydro-4,5-epoxybenzo(a)pyrene
CHEBI:34560
4,5-dihydro-4,5-epoxybenzpyrene
3b,4a-dihydrobenzo[1,2]pyreno[4,5-b]oxirene #
XGZQLNASOQVQTD-UHFFFAOYSA-N
benzo[a]pyrene 4,5-epoxide
3b,4a-dihydrobenzo[1,12]tetrapheno[5,6-b]oxirene
Q27116150
18-oxahexacyclo[10.7.2.03,8.09,20.016,21.017,19]henicosa-1,3,5,7,9(20),10,12(21),13,15-nonaene
DTXSID70958640
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbopolycyclic compoundA polyclic compound in which all of the ring members are carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Glutathione Metabolism III1219

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (81.63)18.7374
1990's6 (12.24)18.2507
2000's3 (6.12)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.09 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index4.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]